Relation of epicardial fat thickness and brachial flow-mediated vasodilation with coronary artery disease

Hasan Kaya1, Faruk Ertaş1, Mustafa Oylumlu1

  • 1Department of Cardiology, Dicle University, Faculty of Medicine, Diyarbakır, Turkey.

Insights

Epicardial fat thickness (EFT) is a significant predictor of coronary artery disease (CAD). Higher EFT levels were associated with CAD, suggesting its utility in risk stratification.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Risk Factor Assessment

Background:

  • Coronary artery disease (CAD) remains a leading cause of mortality worldwide.
  • Early identification of individuals at risk for CAD is crucial for effective management.
  • Epicardial fat thickness (EFT) and flow-mediated vasodilation (FMD) are potential non-invasive markers for cardiovascular health.

Purpose of the Study:

  • To investigate the association between epicardial fat thickness (EFT) and coronary artery disease (CAD).
  • To examine the relationship between flow-mediated vasodilation (FMD) and CAD.
  • To determine the predictive value of EFT in identifying CAD presence.

Main Methods:

  • Echocardiographic measurement of EFT and FMD in 64 patients with suspected stable angina.
  • Patients categorized into CAD (n=34) and normal coronary arteries (NCA, n=30) groups based on coronary angiography.
  • Multivariate logistic regression analysis performed to identify independent predictors of CAD.

Main Results:

  • EFT was significantly higher in the CAD group (6.43 ± 0.90 mm) compared to the NCA group (5.35 ± 0.75 mm).
  • FMD was significantly lower in the CAD group (6.41 ± 2.51%) versus the NCA group (8.33 ± 3.45%).
  • EFT (OR: 6.325) and age (OR: 1.093) were independent predictors of CAD. A cut-off EFT of ≥5.8mm showed 77% sensitivity and 70% specificity for CAD detection.

Conclusions:

  • Echocardiographic assessment of EFT is independently associated with the presence of CAD.
  • EFT serves as a valuable tool for cardiometabolic risk stratification.
  • EFT measurement can aid in guiding therapeutic interventions for CAD prevention and management.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...